Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D ROSENFELD

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Journal of Diseases of Children (1960)|December 1, 1989
High prevalence rate of human papillomavirus infection and association with abnormal papanicolaou smears in sexually active adolescentsW D Rosenfeld, S H Vermund, S J Wentz, et al.
The Journal of Pediatrics|August 1, 1992
Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescentsW D Rosenfeld, E Rose, S H Vermund, et al.
Archives of Pediatrics & Adolescent Medicine|April 18, 2000
The potential role of an adult mentor in influencing high-risk behaviors in adolescentsS R Beier, W D Rosenfeld, K C Spitalny, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 1, 1995
Comparison of rapid diagnostic methodologies for Chlamydia and gonorrhea in an urban adolescent population: a pilot studyD K Bryant, A S Fox, I Spigland, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1991
Storage artifact increases helper T lymphocytes and helper-to-suppressor T lymphocyte ratio to normal levels in a patient with acquired immune deficiency related complexB Moll, W D Rosenfeld, J Frager, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|November 1, 1995
Guidelines for adolescent health research: a position paper of the society for adolescent medicineJ S Santelli, W D Rosenfeld, R H DuRant, et al.
Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Diseases of Children (1960)|December 1, 1989
High prevalence rate of human papillomavirus infection and association with abnormal papanicolaou smears in sexually active adolescentsW D Rosenfeld, S H Vermund, S J Wentz, et al.
The Journal of Pediatrics|August 1, 1992
Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescentsW D Rosenfeld, E Rose, S H Vermund, et al.
Archives of Pediatrics & Adolescent Medicine|April 18, 2000
The potential role of an adult mentor in influencing high-risk behaviors in adolescentsS R Beier, W D Rosenfeld, K C Spitalny, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 1, 1995
Comparison of rapid diagnostic methodologies for Chlamydia and gonorrhea in an urban adolescent population: a pilot studyD K Bryant, A S Fox, I Spigland, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1991
Storage artifact increases helper T lymphocytes and helper-to-suppressor T lymphocyte ratio to normal levels in a patient with acquired immune deficiency related complexB Moll, W D Rosenfeld, J Frager, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|November 1, 1995
Guidelines for adolescent health research: a position paper of the society for adolescent medicineJ S Santelli, W D Rosenfeld, R H DuRant, et al.
Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.
Pageof 2